Pronto Diagnostic Kits

PRONTO® has developed and introduced to the market over 30 test kits which provide rapid and accurate assays for detecting polymorphisms in DNA sequences associated with genetic diseases and predisposition to disease. The kits are suitable for both small and large-scale clinical genetic analysis.

Our products are based on the patented PRONTO® technology. The technology forms the basis for one of the first commercial SNP assays for clinical diagnostics that utilizes a single-nucleotide primer extension ELISA assay.

The PRONTO® product line has received CE certification and meets the highest international quality production standards including ISO 9001:2000, EN 46001, and ISO 13485.

Pronto Diagnostics provides highly professional technical support. Its product specialists are dedicated to supporting the company’s customers worldwide. Its proprietary technologies and applications allow the company to meet growing market needs, while setting the standard for clinical genetic analysis products.


Comments are closed.

Search Table:
1.Mucolipidosis IV
2.Niemann Pick Type A, Type B
MCOLN (Del[ex 1-7],IVS3-2A>G), SMPD1 (L302P, fsP330, R496L, R608del) 6 24 F9954
5FU Susceptibility DPD (DPD*2A G/A variant) 1 48 F9984
1. Canavan
2. Bloom Syndrome
3. Fanconi Anemia C
4. Familial Dysautonomia
ASPA (693C>A, 854A>C) BLM (2281del6ins7) FANCC (IVS4+4A>T) IKBKAP (2507+6T>C, R696P) 6 24 F9953
Alpha-1 Antitrypsin Deficiency SERPINA1 [AAT] (PiZ) 1 144 F9971
Predisposition to Colorectal Cancer APC (3920T>A) 1 96 F9907
Predisposition to Hypercholesterolemia, Cardiovascular Disease APOE (ε2, ε3, ε4) 2 48 F9903
1. Ataxia Telangiectasia
2. Fanconi Anemia A
ATM (103C>T) FANCA (2127-2173insG, 4275delT) 3 48 F9982
1. Bloom Syndrome
2. Fanconi Anemia C
BLM (2281del6ins7) FANCC (IVS4+4A>T) 2 48 F9931
Predisposition to Breast and Ovarian Cancer BRCA1 (185delAG, 5382insC) BRCA2 (6174delT) 3 48 F9911
Canavan ASPA (693C>A, 854A>C) 2 48 F9906
Cystic Fibrosis CFTR (F508del, G542X, W1282X, N1303K, 3849+10KbC>T) 5 24 F9901
Cystic Fibrosis CFTR (F508del, G542X, W1282X, N1303K, 3849+10KbC>T, D1152H) 6 24 F9943
Cystic Fibrosis CBAVD - congenital
bilateral absence of the vas deferens
CFTR (5T/7T/9T) 1 48 F9945
Clopidogrel metabolism CYP2C19 (*2,*3,*4,*5) ABCB1 (3435C>T) 5 24 F9985
Predisposition to Thrombosis F5 / Factor V (1691G>A) 1 96 F9905
Familial Dysautonomia
(Riley Day Syndrome)
IKBKAP (2507+6T>C) 1 96 F9948
Familial Dysautonomia
(Riley Day Syndrome)
IKBKAP (2507+6T>C, R696P) 2 48 F9963
Familial Mediterranean Fever MEFV (M680I, M694V, M694I, V726A, E148Q) 5 24 F9904
Gaucher GBA (84GG, IVS2+1G>A, N370S [1226A>G], D409H [1342G>C], L444P [1448T>C], V394L [1297G>T]) 6 24 F9900
Gaucher GBA (84GG, IVS2+1G>A, N370S [1226A>G], R496H [1604G>A], L444P [1448T>C], V394L [1297G>T]) 6 24 F9900-1
Hereditary Hemochromatosis HFE (C282Y, H63D, S65C) 3 32 F9949
Mucolipidosis IV MCOLN1 (Del[ex1-7], IVS3-2A>G) 2 48 F9960
1. Maple Syrup Urine Disease 1b
2. Nemaline Myopathy 2
BCKDHB (R183P) 2 72 F9975/1
Predisposition to Thrombosis MTHFR (677C>T) 1 96 F9910
Niemann Pick Type A,
Type B
SMPD1 (L302P, fsP330, R496L, R608del) 4 36 F9961
Predisposition to Thrombosis F2 / Factor II (20210G>A) 1 96 F9909
Alpha-1 Antitrypsin Deficiency SERPINA1 [AAT] (PiZ and PiS) 2 96 F9965
Tay-Sachs HEXA (1278insTATC, G269S [805G>A], IVS12+1G>C) 3 48 F9958
Tay-Sachs HEXA (1278insTATC,G269S, IVS12+1G>C, R170Q, IVS5-2A>G, F304del) 6 24 F9981
Predisposition to Thrombosis F5 / Factor V (1691G>A) F2 / Factor II (20210G>A) MTHFR (677C>T) 3 32 F9923
Usher Syndrome PCDH15 (R245X) 1 144 F9967/1
Warfarin dosage CYP2C9 (*2 [430C>T], *3 [1075A>C]) VKORC1 (-1639G>A, 5417G>T) 4 36 F9980
Warfarin dosage CYP2C9 (*2 [430C>T], *3 [1075A>C]) VKORC1(-1639G>A) 3 48 F9979
48 samples F9925
ProntoTaq™ -
HotStart Taq polymerase
50 µL (5 units/µL) F9101